Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities.

PLoS Med · 2021 · PMC8483386 · PMID 34591861

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

If pharmaceutical manufacturers or MRAs are able to upload NIR/Raman spectra to secure cloud repositories, to automatically update a country’s screening devices as formulations change or new products become available, there are likely to be significant public health benefits.

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.